Investigation of Hemoglobin Oxygenation With Third Harmonic Generation Microscopy
1 other identifier
observational
100
1 country
1
Brief Summary
The specific aims of the project are performing a pre-clinical study on a human model and evaluating the oxygenation and other status of human erythrocytes by spectrally-resolved third harmonic generation (srTHG) microscopy . By analyzing the partitioned third harmonic generation (THG) spectra of oxygenated and deoxygenated erythrocytes ex vivo, the investigators aim to provide a reference standard for quantifying oxygenation and molecular status in this project.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 5, 2018
CompletedFirst Submitted
Initial submission to the registry
June 11, 2018
CompletedFirst Posted
Study publicly available on registry
August 7, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedAugust 21, 2024
November 1, 2023
6.9 years
June 11, 2018
August 19, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Observe the extent of tumor growth via morphological information
To observe the extent of tumor growth (with units of mm2) via morphological information. Morphological information are presented as density and shape of red blood cells.
2 years
Observe the extent of tumor growth via spectral THG intensity distribution
To observe the extent of tumor growth (with units of mm2) via spectral THG distributions. The spectral distributions are presented by the ratio between different channels. And the ratio can be calculated by analyzing the excited fluorescence intensity.
2 years
Change in spectral THG strength distribution
Obtain THG strength in 3 different channels for chemically treated whole blood samples for oxygenation, deoxygenation and other status. The spectral distributions are presented by the ratio between different channels.
2 years
Secondary Outcomes (1)
Quantify the extent of diseases in spectral THG strength distribution
1 year
Eligibility Criteria
Volunteers with any genders with the age older than 20 years.
You may qualify if:
- older than 20 years old
You may not qualify if:
- Vulnerable groups, such as pregnant women, prisoners, students, mentally handicapped, aborigines, etc.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University Hospital
Taipei, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 11, 2018
First Posted
August 7, 2018
Study Start
February 5, 2018
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
August 21, 2024
Record last verified: 2023-11